D, D., CJ, D., R, S., A, F., W, E., M, A., . . . S, M. (2026). LSD microdosing in major depressive disorder: Results from an open-label trial. Neuropharmacology, 283, 110762. https://doi.org/10.1016/j.neuropharm.2025.110762
Chicago Style (17th ed.) CitationD, Daldegan-Bueno, et al. "LSD Microdosing in Major Depressive Disorder: Results from an Open-label Trial." Neuropharmacology 283 (2026): 110762. https://doi.org/10.1016/j.neuropharm.2025.110762.
MLA (9th ed.) CitationD, Daldegan-Bueno, et al. "LSD Microdosing in Major Depressive Disorder: Results from an Open-label Trial." Neuropharmacology, vol. 283, 2026, p. 110762, https://doi.org/10.1016/j.neuropharm.2025.110762.
Warning: These citations may not always be 100% accurate.